Literature DB >> 2373873

Antibody to the capsular polysaccharide/adhesin protects rabbits against catheter-related bacteremia due to coagulase-negative staphylococci.

Y Kojima1, M Tojo, D A Goldmann, T D Tosteson, G B Pier.   

Abstract

A rabbit model of catheter-related bacteremia was developed to study immunity to the capsular polysaccharide/adhesin (PS/A) of coagulase-negative staphylococci. Catheters colonized by coagulase-negative staphylococci were inserted into the right jugular vein and attached to a subcutaneous osmotic pump, and blood cultures were obtained over 14 days. Nonimmune rabbits were bacteremic for 6-8 days after infection, hypoglycemic, and hyperlipidemic and had strong immune responses to teichoic acid but not to PS/A. PS/A immunization, but not teichoic acid immunization, reduced the number of bacteremic days by approximately 60%, diminished the hypoglycemia and hyperlipidemia, and ablated the immune responses to teichoic acid. Passive infusion of PS/A-specific polyclonal and monoclonal antibodies using a separate, noninfected catheter-pump combination implanted in the left jugular protected against both bacteremia and hematogenous colonization of this contralateral catheter.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2373873     DOI: 10.1093/infdis/162.2.435

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated infection in a rat model.

Authors:  M E Rupp; J S Ulphani; P D Fey; D Mack
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 2.  The exceptionally broad-based potential of active and passive vaccination targeting the conserved microbial surface polysaccharide PNAG.

Authors:  David Skurnik; Colette Cywes-Bentley; Gerald B Pier
Journal:  Expert Rev Vaccines       Date:  2016-03-16       Impact factor: 5.217

3.  Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.

Authors:  Tomás Maira-Litrán; Andrea Kropec; Donald A Goldmann; Gerald B Pier
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Development of Antistaphylococcal Vaccines.

Authors:  Jean C. Lee
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

Review 5.  Pathogenesis of infections related to intravascular catheterization.

Authors:  D A Goldmann; G B Pier
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

6.  Activity and specificity of a mouse monoclonal antibody to ferric aerobactin.

Authors:  D le Roy; D Expert; A Razafindratsita; A Deroussent; J Cosme; C Bohuon; A Andremont
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

7.  Capsular polysaccharide serotyping scheme for Staphylococcus epidermidis.

Authors:  A Fattom; S Shepherd; W Karakawa
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

8.  Isolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime.

Authors:  E Muller; J Hübner; N Gutierrez; S Takeda; D A Goldmann; G B Pier
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

9.  Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide.

Authors:  Tomás Maira-Litrán; Andrea Kropec; C Abeygunawardana; Joseph Joyce; George Mark; Donald A Goldmann; Gerald B Pier
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

10.  The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin.

Authors:  D McKenney; J Hübner; E Muller; Y Wang; D A Goldmann; G B Pier
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.